SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Bassett LW, Liu TH, Giuliano AE, Gold RH. The prevalence of carcinoma in palpable vs impalpable: mammographically detected lesions. AJR. 1991; 157: 21-24.
  • 2
    Krishnamurthy S. Current applications and future prospects of fine-needle aspiration biopsy of locoregional lymph nodes in the management of breast cancer. Cancer. 2009; 117: 451-462.
  • 3
    Bonnema J, van Geel AN. Van Ooijen B, et al. Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: New diagnostic method. World J Surg. 1997; 21: 270-274.
  • 4
    Verbanck J, Vandewiele I, De Winter H, et al. Value of axillary ultrasonography and sonographically guided puncture of axillary nodes: a prospective study in 144 consecutive patients. J Clin Ultrasound. 1997; 25: 53-56.
  • 5
    De Kanter AY, van Eijck CHJ, van Geel AN, et al. Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg. 1999; 86: 1459-1462.
  • 6
    de Freitas R Jr, Costa MV, Schneider SV, Nicolau MA, Marussi E. Accuracy of ultrasound and clinical examination of the diagnosis of axillary lymph node metastasis in breast cancer. Eur J Surg Oncol. 1991; 17: 240-244.
  • 7
    Lam WW, Yang WT, Chan YL, Stewart IE, Metreweli C, King W. Detection of axillary lymph node metastases in breast carcinoma by technetium 99m sestamibi breast scintigraphy, ultrasound and conventional mammography. Eur J Nucl Med. 1996; 23: 498-503.
  • 8
    Perre CI, de Hooge P, Leguit P. Little extra information with ultrasound studies of the axillary glands in patients with breast carcinoma [in Dutch]. Ned Tijdschr Geneeskd. 1991; 135: 1275-1277.
  • 9
    Tate JJ, Lewis V, Archer T, Guyer PG, Royle GT. Taylor I. Ultrasound detection of axillary lymph node metastasis in breast cancer. Eur J Surg Oncol. 1989; 15: 139-141.
  • 10
    Pamilo M, Soiva M, Lavast EM. Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastasis in breast cancer patients. J Ultrasound Med. 1989; 8: 115-120.
  • 11
    Bruneton JN, Caramella E, Hery M, Aubanel D, Manzino JJ, Picard JL. Axillary lymph node metastases in breast cancer: preoperative direction with US. Radiology. 1986; 158: 325-326.
  • 12
    Mustonen P, Farin P, Kosunen O. Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer. Ann Chir Gynaecol. 1990; 79: 15-18.
  • 13
    Rao R, Lilley L, Andrews V, Radford L, Ulissey M. Axillary staging by percutaneous biopsy: sensitivity of fine-needle aspiration versus core needle biopsy. Ann Surg Oncol. 2009; 16: 1170-1175.
  • 14
    Kuenen-Boumeester V, Menke-Pluymers M, de Kanter AY, Obdeijn IM, Urich D, Van Der Kwast TH. Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure. Eur J Cancer. 2003; 39: 170-174.
  • 15
    Van Rijk MC, Duerloo EE, Nieweg OE, et al. Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol. 2006; 13: 31-35.
  • 16
    Krishnamurthy S, Sneige N, Bedi DG, et al. Role of ultrasound-guided fine needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer. 2002; 95: 982-988.
  • 17
    Ciatto S, Brancato B, Risso G, et al. Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging. Breast Cancer Res Treat. 2007; 103: 85-91.
  • 18
    Giliseen F, Oostenbroek R, Storm R, Westenend P, Plaisier P. Prevention of futile sentinel node procedures in breast cancer: ultrasonography of the axilla and fine-needle aspiration cytology are obligatory. Eur J Surg Oncol. 2008; 34: 497-500.
  • 19
    Mills P, Sever A, Weeks J, Fish D, Jones S, Jones P. Axillary ultrasound assessment in primary breast cancer: an audit of 653 cases. Breast J. 2010; 16: 460-463.
  • 20
    Waljee JF, Newman LA. Neoadjuvant systemic therapy and the surgical management of breast cancer. Surg Clin North Am. 2007; 87: 399-415.
  • 21
    Alkuwari E, Auger M. Accuracy of fine needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation. Cancer. 2008; 114: 89-93.
  • 22
    SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2008. http://seer.cancer.gove/scr/1975-2006/. Accessed December 3, 2010.
  • 23
    Silverman JF, Masood S, Ducatman BS, Wang HH, Sneige N. Can FNA biopsy separate atypical hyperplasia, carcinoma in situ, and invasive carcinoma of the breast?: Cytomorphologic criteria and limitations in diagnosis. Diagn Cytopathol. 1993; 9: 713-728.
  • 24
    Nassar A. Core needle biopsy versus fine needle aspiration biopsy in breast—a historical perspective and opportunities in the modern era [Published online ahead of print October 14, 2010]. Diagn Cytopathol. doi: 10.1002/dc21433.
  • 25
    Rouesse J, Friedman S, Sarrazin D, et al. Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol. 1986; 4: 1765-1771.
  • 26
    Chavez-MacGregor M, Gonzalez-Angulo AM. Breast cancer, neoadjuvant chemotherapy and residual disease. Clin Transl Oncol. 2010; 12: 461-467.